The immunoprotein diagnostic market share is expected to increase by USD 11.48 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 8.64%.
This immunoprotein diagnostic market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers immunoprotein diagnostic market segmentations by application (oncology and endocrinology testing, infectious disease testing, autoimmune testing, and allergy testing), end-user (hospitals and clinics and diagnostic laboratories), and geography (North America, Europe, Asia, and ROW). The immunoprotein diagnostic market report also offers information on several market vendors, including Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., and Thermo Fisher Scientific Inc. among others.
What will the Immunoprotein Diagnostic Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Immunoprotein Diagnostic Market Size for the Forecast Period and Other Important Statistics
Immunoprotein Diagnostic Market: Key Drivers, Trends, and Challenges
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increasing prevalence of infectious diseases is notably driving the immunoprotein diagnostic market growth, although factors such as high cost of products may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the immunoprotein diagnostic industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Immunoprotein Diagnostic Market Driver
The increasing prevalence of infectious diseases is one of the key factors driving the growth of the global immunoprotein diagnostic testing market. The incidences of COVID-19 have increased significantly across the world. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mainly responsible for COVID-19 infection. The outbreak of the COVID-19 pandemic in 2020 has affected several countries. For instance, according to the data published by the CDC, in the US, the total number of people reported with COVID-19 increased from 33,404 on March 23, 2020, to 39 million on September 01, 2021. Similarly, the Public Health England (PHE) stated that the number of confirmed cases of COVID-19 reported in the UK increased from 29,474 on April 1, 2020, to 6.8 million on September 01, 2021. The rising number of such infectious diseases is driving the demand for advanced diagnostic procedures to provide effective treatment to patients and thereby reduce the mortality rate due to infectious diseases. This, in turn, is boosting the growth of the global immunoprotein diagnostic testing market during the forecast period.
Key Immunoprotein Diagnostic Market Trend
The growing focus on next-generation products will fuel the global immunoprotein diagnostic testing market growth. Technological advances in immunoprotein diagnostics testing products will increase their adoption. The use of multiple assays for the detection of antigens and antibodies will increase the need for the screening of the diseases. Therefore, companies are focusing on developing advanced assays for immunoprotein diagnostic testing. For instance, Aushon BioSystems offers Ciraplex ULTRA Ultrasensitive Human 3-Plex IL-1β, IL-6, IL-10 Multiplexed Assay, which combines the ultrasensitive detection of immunoproteins with multiplexing to diagnose and treat diseases. The product can obtain low levels of detection of proteins for up to 3 biomarkers in one assay. Similarly, Merck KGaA (Merck) launched the MILLIPLEX MAP Human High Sensitivity cytokine panel, which was designed for use with the Luminex FLEXMAP 3D platform. The assay is fast, cost-effective, and generates results four times higher when compared with traditional assays using a smaller sample size. Such factors will increase the market growth during the forecast period.
Key Immunoprotein Diagnostic Market Challenge
The limited capability and high complexity of the procedure is a major challenge for the global immunoprotein diagnostic testing market growth. Immunoassays can only measure the concentration of an antigen. For infectious diseases, they can measure a specific bacterium or viral antigen. These assays may fail to detect the mutations of the original pathogens and the components cross-reacting with the antibodies or antigen-positive dead cells. Hence, they may provide false-positive results. Enzyme-linked immunosorbent assay (ELISA) is the gold standard diagnostic test for HIV. However, it requires monoclonal antibodies (mAb), which are expensive and difficult to obtain; a specialized instrument reader, and a washer, which may provide results that are not absolute or can detect only a specific antigen. Hence, the limited capability of the procedure could affect the growth of the market during the forecast period
This immunoprotein diagnostic market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Parent Market Analysis
Technavio categorizes the global immunoprotein diagnostic testing market as a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the immunoprotein diagnostic market during the forecast period.
Who are the Major Immunoprotein Diagnostic Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Bio Rad Laboratories Inc.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Siemens AG
- Sofina SA
- The Carlyle Group Inc.
- Thermo Fisher Scientific Inc.
This statistical study of the immunoprotein diagnostic market encompasses successful business strategies deployed by the key vendors. The immunoprotein diagnostic market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
- Abbott Laboratories - The company offers immunoprotein diagnostic testing such as Abbott RealTime SARS-C0V-2 assay which is an Emergency Use Authorization (EUA) test for diagnosis of SARS-CoV-2 virus infection.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The immunoprotein diagnostic market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Immunoprotein Diagnostic Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the immunoprotein diagnostic market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the global life sciences tools and services market includes the following core components:
- Inputs
- Inbound logistics
- Operations
- Outbound logistics
- Marketing and sales
- Service
- Support activities
- Innovation
The report has further elucidated on other innovative approaches being followed by service providers to ensure a sustainable market presence.
Which are the Key Regions for Immunoprotein Diagnostic Market?
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market’s growth will originate from North America during the forecast period. The US, and Canada are the key markets for immunoprotein diagnostic market in North America. Market growth in this region will be the than the growth of the market in regions.
The increasing prevalence of infectious diseases will facilitate the immunoprotein diagnostic market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The immunoprotein diagnostic testing market was positively impacted by the COVID-19 pandemic in 2020. Regulatory authorities are also extending support to approve these immunoprotein diagnostic testing kits to combat the pandemic. Moreover, the market witnessed several approvals and the launch of immunoprotein diagnostic testing kits for the COVID-19 detection test. Therefore, the approval of immunoprotein diagnostic testing kits will drive the regional market growth during the forecast period.
What are the Revenue-generating Application Segments in the Immunoprotein Diagnostic Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The immunoprotein diagnostic market share growth by the Oncology and endocrinology testing segment will be significant during the forecast period. The high incidence of cancer and the growing need for diagnosis is expected to drive the growth of the market. For solid tumor analysis, multiplex immunoassay tests are commonly used. Immunoprotein diagnostic tests that offer low-range sensitivity are now available in the market.
This report provides an accurate prediction of the contribution of all the segments to the growth of the immunoprotein diagnostic market size and actionable market insights on post COVID-19 impact on each segment.
|
Immunoprotein Diagnostic Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.64% |
|
Market growth 2021-2025 |
$ 11.48 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
9.34 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 37% |
|
Key consumer countries |
US, Germany, UK, Canada, China, and Japan |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Immunoprotein Diagnostic Market Report?
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive immunoprotein diagnostic market growth during the next five years
- Precise estimation of the immunoprotein diagnostic market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the immunoprotein diagnostic industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of immunoprotein diagnostic market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch